Sentinel Biomedical is a pioneering comparative health company committed to research and scientific innovation. The company’s primary focus is investigating canine cancers and identifying biological changes and environmental influences that may be shared with human cancers, making canines true watchdogs in the area of human health. By taking a comparative approach to research, the company aspires to accelerate the pace of cancer-related discoveries leading to improved diagnosis, treatment and patient outcomes. Sentinel Biomedical created the nation’s first and most reliable early detection system to allow for rapid results and early intervention of canine bladder cancer. It continues to develop innovative, forensic level products supported by robust research, proven science and leading oncology experts.